79 filings
Page 2 of 4
425
OACB
Oaktree Acquisition Corp II
6 Apr 22
Business combination disclosure
7:53am
8-K
OACB
Oaktree Acquisition Corp II
6 Apr 22
Upon launch, HUKYNDRA® will be one of two citrate-free, high-concentration adalimumab biosimilars on the European market
7:50am
10-K
2021 FY
OACB
Oaktree Acquisition Corp II
Annual report
30 Mar 22
5:00pm
425
ALVO
Alvotech
23 Mar 22
Business combination disclosure
5:03pm
8-K
OACB
Oaktree Acquisition Corp II
23 Mar 22
Regulation FD Disclosure
4:59pm
425
ALVO
Alvotech
23 Mar 22
Business combination disclosure
4:05pm
425
ALVO
Alvotech
8 Mar 22
Business combination disclosure
5:28pm
8-K
OACB
Oaktree Acquisition Corp II
8 Mar 22
Regulation FD Disclosure
5:26pm
425
OACB
Oaktree Acquisition Corp II
28 Feb 22
Business combination disclosure
7:02am
425
ALVO
Alvotech
23 Feb 22
Business combination disclosure
5:15pm
SC 13G
OACB
Oaktree Acquisition Corp II
16 Feb 22
Oaktree Acquisition Corp. II / MILLENNIUM MANAGEMENT ownership change
4:13pm
425
OACB
Oaktree Acquisition Corp II
14 Feb 22
Business combination disclosure
9:25pm
SC 13G/A
OACB
Oaktree Acquisition Corp II
7 Feb 22
Oaktree Acquisition Corp. II / INTEGRATED CORE STRATEGIES ownership change
4:43pm
425
OACB
Oaktree Acquisition Corp II
2 Feb 22
Business combination disclosure
7:30am
425
OACB
Oaktree Acquisition Corp II
18 Jan 22
Business combination disclosure
5:25pm
8-K
OACB
Oaktree Acquisition Corp II
18 Jan 22
Entry into a Material Definitive Agreement
5:23pm
425
OACB
Oaktree Acquisition Corp II
10 Jan 22
Business combination disclosure
8:26am
425
OACB
Oaktree Acquisition Corp II
16 Dec 21
Business combination disclosure
4:16pm
8-K
OACB
Oaktree Acquisition Corp II
15 Dec 21
Regulation FD Disclosure
12:00am
10-Q/A
2021 Q3
OACB
Oaktree Acquisition Corp II
13 Dec 21
Quarterly report (amended)
4:09pm